Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biomarin Pharmaceuticals (NQ: BMRN )

79.22 USD -0.18 (-0.23%)
Streaming Delayed Price Updated: 10:27 AM EDT, Apr 19, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Biomarin Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9
...
83 84 Next >
First Trust Lunt U.S. Factor Rotation ETF Experiences Big Outflow
Symbols mentioned in this story: FCTR, SPLK, BMRN, REGN Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
BioMarin Announces New and Updated Data at 2021 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting Demonstrating Commitment to Understanding Achondroplasia and P
Normal Progression of Bone Age with Chronological Age Over 60 Months with Vosoritide for Children with Achondroplasia 
From PR Newswire
BioMarin to Host First Quarter 2021 Financial Results Conference Call and Webcast on Thursday, April 29 at 4:30pm ET
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a conference call and webcast on Thursday, April 29,... 
From PR Newswire
BioMarin Pharmaceutical Moves Up In Market Cap Rank, Passing Howmet Aerospace
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component BioMarin Pharmaceutical Inc (BMRN) was identified as having a larger market cap than the smaller end of the... 
Tags Stocks
From Market News Video
Noteworthy Wednesday Option Activity: BMRN, PLCE, KEX
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in BioMarin Pharmaceutical Inc (BMRN), where a total of 5,622 contracts have traded so far,... 
Tags Stocks
From Market News Video
PBE's Holdings Could Mean 19% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
BioMarin Announces Oral Presentation at ENDO2021, the Endocrine Society's Annual Meeting, with Data Demonstrating 2 Years of Treatment Benefit in Children with Achondroplasia Treated with Vosoritide
Height Gain is Maintained in 2nd Year of Treatment 
From PR Newswire
BIOMARIN INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of BioMarin Pharmaceutical Inc. - BMRN
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into BioMarin... 
From Business Wire News Releases
7 Pharmaceutical Stocks Working on Their Next Blockbuster
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>Pharmaceutical stocks are a sector with unique success factors. One... 
Tags Stocks to Buy Market News NASDAQ:MRTX,NYSE:NVS,NYSE:BHVN,NASDAQ:BMRN,NYSE:NVO,OTCMKTS:DSNKY,NASDAQ:ARGX,NASDAQ:AMGN
From InvestorPlace
This Underperforming Biotech Is Ready to Beat the Market
Incyte is betting bigger on ruxolitinib to bring back growth. 
Tags MRK RHHBY PFE
From Motley Fool
Is Pfizer Stock A Buy As The Company Bolsters Its Covid Vaccine Supply?
Pfizer stock took a hit in early February on a disappointing fourth-quarter report, though the company called for $15 billion in full-year Covid vaccine sales. So, is Pfizer stock a buy now? 
From Investor's Business Daily
BioMarin's Hemophilia Gene Therapy Scores RMAT Designation In US
The FDA hasgranted Regenerative Medicine Advanced Therapy(RMAT) designation toBioMarin Pharmaceutical ... 
Tags Benzinga General gene therapy
From Benzinga
BioMarin Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to Valoctocogene Roxaparvovec, Investigational Gene Therapy for Hemophilia A
RMAT Designation Granted by FDA During Bleeding Disorders Awareness Month 
From PR Newswire
BioMarin Completes Full Enrollment in Phase 2 Study of Vosoritide for Treatment of Infants and Young Children with Achondroplasia
Topline data expected to be available in mid-2022 
From PR Newswire
BIOMARIN INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. - BMRN
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into BioMarin... 
From PR Newswire
Noteworthy Friday Option Activity: BMRN, ZNGA, ZYXI
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in BioMarin Pharmaceutical Inc (BMRN), where a total of 4,955 contracts have traded so far,... 
Tags Stocks
From Market News Video
Biomarin Pharmaceutical Inc (BMRN) Q4 2020 Earnings Call Transcript
BMRN earnings call for the period ending December 31, 2020. 
Tags BMRN Market News
From Motley Fool
BioMarin Announces Fourth Quarter and Record Full-year 2020 Financial Results and Corporate Updates
- Full-year 2020 Total Revenues Increased 9% to $1.86 billion 
From PR Newswire
The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags NUVA RCEL KALA
From Benzinga
BioMarin to Participate in Four Upcoming Virtual Investor Conferences
- 2021 SVB Leerink Global Healthcare Conference on February 26 at 11:20am ET 
From PR Newswire
The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings
Biotech stocks pulled back along with the broader market in the holiday-shortened week ended Feb 19. Earnings news flow was light before ... 
Tags ARNA LMAT VIR
From Benzinga
BioMarin Appoints Former Goldman Sachs Partner and Life Sciences Executive, Maykin Ho, Ph.D. to Board of Directors
BioMarin Pharmaceutical Inc. (Nasdaq:BMRN), a global leader in providing therapies for rare genetic diseases, today announced the appointment of former Goldman Sachs partner and executive in the life... 
From PR Newswire
Is Pfizer Stock A Buy On Guidance For $15 Billion In Covid Vaccine Sales?
Pfizer stock took a hit in early February on a disappointing fourth-quarter report, though the company called for $15 billion in full-year Covid vaccine sales. So, is Pfizer stock a buy now? 
From Investor's Business Daily
BioMarin Earns Top Marks in Human Rights Campaign's 2021 Corporate Equality Index
- BioMarin earns a 100 score on the Human Rights Campaign Foundation's annual assessment of LGBTQ workplace equality 
From PR Newswire
Implied USMV Analyst Target Price: $73
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
BioMarin to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call and Webcast on Thursday, February 25 at 4:30pm ET
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a conference call and webcast on Thursday, February... 
From PR Newswire
Is Now A Good Time To Buy BioMarin Stock?
Shares in this biotech company are down considerably from where they were this summer, but the stock looks ready to take off again. 
Tags BMRN Market News
From Motley Fool
NASDAQ:BMRN Long-Term Investor Notice: Investigation of Potential Wrongdoing at BioMarin Pharmaceutical Inc.
San Diego, CA -- (SBWIRE) -- 01/18/2021 -- An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of BioMarin Pharmaceutical Inc.. 
From SBWire - Latest Press Releases
BIOMARIN INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. - BMRN
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into BioMarin... 
From Business Wire News Releases
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Long Term Investor Notice: Investigation of Potential Wrongdoing
San Diego, CA -- (SBWIRE) -- 01/14/2021 -- Certain directors of BioMarin Pharmaceutical Inc are under investigation over potential breaches of fiduciary duties. 
From SBWire - Latest Press Releases
< Previous 1 2 3 4 5 6 7 8 9
...
83 84 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.